Cargando…

Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region

All-trans retinoic acid (ATRA) is well established as differentiation therapy for acute promyelocytic leukemia (APL) in which the PML–RARα (promyelocytic leukemia-retinoic acid receptor α) fusion protein causes blockade of the retinoic acid (RA) pathway; however, in types of acute myeloid leukemia (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakamoto, K, Imamura, T, Yano, M, Yoshida, H, Fujiki, A, Hirashima, Y, Hosoi, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003419/ https://www.ncbi.nlm.nih.gov/pubmed/24769646 http://dx.doi.org/10.1038/bcj.2014.25

Ejemplares similares

All-trans retinoic acid synergizes with topotecan to suppress AML cells via promoting RARα-mediated DNA damage
por: Xu, Zhifei, et al.
Publicado: (2016)

Molecular pathogenesis of disease progression in MLL-rearranged AML
por: Kotani, Shinichi, et al.
Publicado: (2018)

Initiation of MLL-rearranged AML is dependent on C/EBPα
por: Ohlsson, Ewa, et al.
Publicado: (2014)

Anti-PML-RARα shRNA sensitises promyelocytic leukaemia cells to all-trans retinoic acid
por: Casey, Nicholas P, et al.
Publicado: (2012)

DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy
por: Liu, Wei, et al.
Publicado: (2014)

Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression
por: Centritto, Floriana, et al.
Publicado: (2015)

The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML
por: Rasouli, Milad, et al.
Publicado: (2023)

FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
por: Sheng, Yue, et al.
Publicado: (2020)

The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML
por: Heikamp, Emily B., et al.
Publicado: (2022)

NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK
por: Xiao, Chunlan, et al.
Publicado: (2016)

Developmental expression of retinoic acid receptors (RARs)
por: Dollé, Pascal
Publicado: (2009)

Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML
por: Negri, A., et al.
Publicado: (2023)

Control of Innate and Adaptive Lymphocytes by the RAR-Retinoic Acid Axis
por: Kim, Chang H.
Publicado: (2018)

All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia
por: Nguyen, Chi Huu, et al.
Publicado: (2019)

All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex
por: Wang, Lu, et al.
Publicado: (2022)

Replication stress in MLL-rearrangements
por: Milyavsky, Michael, et al.
Publicado: (2015)

Conditional RARα knockout mice reveal acute requirement for retinoic acid and RARα in homeostatic plasticity
por: Sarti, Federica, et al.
Publicado: (2012)

Epigenetic Priming of AML Blasts for All-trans Retinoic Acid-Induced Differentiation by the HDAC Class-I Selective Inhibitor Entinostat
por: Blagitko-Dorfs, Nadja, et al.
Publicado: (2013)

Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML
por: Lonetti, Annalisa, et al.
Publicado: (2020)

All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK(1/2 )pathway independently of RAR activation
por: Kirchmeyer, Mélanie, et al.
Publicado: (2008)

All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma
por: Peng, Ziyi, et al.
Publicado: (2023)

Erratum: Replication stress in MLL-rearrangements
por: Milyavsky, Michael, et al.
Publicado: (2016)

Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)
por: Fiskus, Warren, et al.
Publicado: (2022)

Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia
por: Richter, William F, et al.
Publicado: (2021)

An Orthologue of the Retinoic Acid Receptor (RAR) Is Present in the Ecdysozoa Phylum Priapulida
por: Fonseca, Elza S. S., et al.
Publicado: (2019)

Identification of Mixed Lineage Leukemia Gene (MLL)/MLLT10 Fusion Transcripts by Reverse Transcription-PCR and Sequencing in a Case of AML With a FISH-Negative Cryptic MLL Rearrangement
por: Ko, Kiwoong, et al.
Publicado: (2015)

Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia
por: van der Linden, Marieke H., et al.
Publicado: (2015)

Antagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cells
por: Hammond, L A, et al.
Publicado: (2001)

The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperation
por: Meier, Ruth, et al.
Publicado: (2022)

RNA binding proteins in MLL-rearranged leukemia
por: Tran, Tiffany M., et al.
Publicado: (2022)

RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells
por: Gianni, Maurizio, et al.
Publicado: (2016)

Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs)
por: Rochette-Egly, Cécile, et al.
Publicado: (2009)

PTGDR expression is upregulated through retinoic acid receptors (RAR) mechanism in allergy
por: García-Sánchez, Asunción, et al.
Publicado: (2019)

Pharmacokinetics of All‐trans Retinoic Acid in Pediatric Patients with Leukemia
por: Takitani, Kimitaka, et al.
Publicado: (1995)

Transdifferentiation of Myoblasts Into Adipocytes by All-Trans-Retinoic Acid in Avian
por: Kim, Dong-Hwan, et al.
Publicado: (2022)

Potential Therapeutic Effect of All-Trans Retinoic Acid on Atherosclerosis
por: Deng, Qile, et al.
Publicado: (2022)

Deregulation of All-Trans Retinoic Acid Signaling and Development in Cancer
por: Brown, Geoffrey
Publicado: (2023)

Identification and characterization of relapse-initiating cells in MLL-rearranged infant ALL by single-cell transcriptomics
por: Candelli, Tito, et al.
Publicado: (2021)

Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1
por: Fiskus, Warren, et al.
Publicado: (2022)

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
por: Zangrando, Andrea, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1tilan9eujdhri176qgkuglfd2